Dapagliflozin Propanediol Monohydrate
Home / API - Under Development / Dapagliflozin Propanediol Monohydrate
CAS No.
461432-26-8
Therapeutic Category
- Anti-diabetic
Innovator Brand
FARXIGA , XIGDUO XR , QTERN
GMP
Available
DMF
Not Available
Filed
-
Under Filing
-
Sample
Available
Indication
Farxiga is a sodium-glucose cotransporter 2 (sglt2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.